Trial intelligence / Profile preview

FMT for Elderly Patients With HFpEF

NCT07628777Phase 2Not yet recruiting

Sponsor
Xijing Hospital
Start
Jun 2026
Primary completion
Mar 2027
Countries
1
01

Overview

A Phase 2 trial of Fecal Microbiota Transplantation Capsule in heart failure with preserved ejection fraction (HFpEF), sponsored by Xijing Hospital. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

Fecal Microbiota Transplantation Capsule
03

Conditions

heart failure with preserved ejection fraction (HFpEF)

Beyond the preview

Go deeper on NCT07628777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07628777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call